Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges

Medical Mycology

Volumn 48, Issue O1, 2010, Pages

  Delhaes, Laurence ^a   Frealle, Emilie ^a   Pinel, Claudine ^b  

^a UNIV LILLE   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

ABPA; biomarkers; cystic fibrosis; serodiagnosis; TARC

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MACROPHAGE DERIVED CHEMOKINE; PRECIPITIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASTHMA; CYSTIC FIBROSIS; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; NONHUMAN; PATIENT MONITORING; REVIEW; SEROLOGY;

ALLERGENS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; BIOLOGICAL MARKERS; CHEMOKINE CCL17; CYSTIC FIBROSIS; HUMANS; IMMUNOGLOBULIN E;

ASPERGILLUS; ASPERGILLUS FUMIGATUS;

EID: 78649917217     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.514301     Document Type: Review

References (88)

1. Hatziagorou E, Walsh TJ, Tsanakas JN, Roilides E. Aspergillus and the paediatric lung. Paediatr Respir Rev 2009; 10: 178-185.
2. Segal BH. Aspergillosis. N Engl J Med 2009; 360: 1870-1884.
3. Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary aspergillosis in cysticf brosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2000; 16: 464-471.
4. Pihet M, Carrere J, Cimon B, et al. Occurrence and relevance off la-mentous fungi in respiratory secretions of patients with cystic fbrosis - a review. Med Mycol 2009; 47: 387-397.
5. Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW. Aspergillusf avus : human pathogen, allergen and mycotoxin producer. Microbiology 2007; 153: 1677-1692.
6. Thia LP, Balfour Lynn IM. Diagnosing allergic bronchopulmonary aspergillosis in children with cysticf brosis. Paediatr Respir Rev 2009; 10: 37-42.
7. Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cysticf brosis- state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37(Suppl. 3): S225-264.
8. Latzin P, Hartl D, Regamey N, et al. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cysticf brosis. Eur Respir J 2008; 31: 36-42.
9. Barton RC, Hobson RP, Denton M, et al. Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cysticf brosis through the detection of immunoglobulin G to Aspergillus fumigatus. Diagn Microbiol Infect Dis 2008; 62: 287-291.
10. Almeida MB, Bussamra MH, Rodrigues JC. ABPA diagnosis in cysticf brosis patients: the clinical utility of IgE specif c to recom-binant Aspergillus fumigatus allergens. J Pediatr (Rio J) 2006; 82: 215-220.
11. Hartl D, Latzin P, Zissel G, et al. Chemokines indicate allergic bron-chopulmonary aspergillosis in patients with cysticf brosis. Am J Respir Crit Care Med 2006; 173: 1370-1376.
12. Kurup VP, Knutsen AP, Moss RB, Bansal NK. Specif c antibodies to recombinant allergens of Aspergillus fumigatus in cysticf brosis patients with ABPA. Clin Mol Allergy 2006; 4: 11.
13. Knutsen AP, Hutcheson PS, Slavin RG, Kurup VP. IgE antibody to Aspergillus fumigatus recombinant allergens in cysticf brosis patients with allergic bronchopulmonary aspergillosis. Allergy 2004; 59: 198-203.
14. Casaulta C, Fluckiger S, Crameri R, Blaser K, Schoeni MH. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cysticf brosis with and without ABPA. Pediatr Allergy Immunol 2005; 16: 217-225.
15. Rapaka RR, Kolls JK. Pathogenesis of allergic bronchopulmonary aspergillosis in cysticf brosis: current understanding and future directions. Med Mycol 2009; 47(Suppl. 1): S331-337.
16. Hafen GM, Hartl D, Regamey N, Casaulta C, Latzin P. Allergic bronchopulmonary aspergillosis: the hunt for a diagnostic serologi-cal marker in cysticf brosis patients. Expert Rev Mol Diagn 2009; 9: 157-164.
17. Tillie-Leblond I, Tonnel AB. Allergic bronchopulmonary aspergillo-sis. Allergy 2005; 60: 1004-1013.
18. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009; 135: 805-826.
19. Schwienbacher M, Israel L, Heesemann J, Ebel F. Asp f6, an Aspergil-lus allergen specif cally recognized by IgE from patients with allergic bronchopulmonary aspergillosis, is differentially expressed during germination. Allergy 2005; 60: 1430-1435.
20. Moss RB. Management of allergic aspergillosis. Curr Allergy Asthma Report 2008; 8: 433-439.
21. Kraemer R, Delosea N, Ballinari P, Gallati S, Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cysticf brosis. Am J Respir Crit Care Med 2006; 174: 1211-1220.
22. Hemmann S, Menz G, Ismail C, Blaser K, Crameri R. Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A. fumigatus -sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitiza-tion. J Allergy Clin Immunol 1999; 104: 601-607.
23. Nikolaizik WH, Weichel M, Blaser K, Crameri R. Intracutaneous tests with recombinant allergens in cysticf brosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy. Am J Respir Crit Care Med 2002; 165: 916-921.
24. Skov M, Pressler T, Jensen HE, Hoiby N, Koch C. Specif c IgG subclass antibody pattern to Aspergillus fumigatus in patients with cysticf brosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 1999; 54: 44-50.
25. Balloy V, Chignard M. The innate immune response to Aspergillus fumigatus. Microbes Infect 2009; 11: 919-927.
26. Bozza S, Gaziano R, Spreca A, et al. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 2002; 168: 1362-1371.
27. Matsukawa A, Lukacs NW, Hogaboam CM, Chensue SW, Kunkel SL. Chemokines and other mediators, 8. Chemokines and their receptors in cell-mediated immune responses in the lung. Microsc Res Tech 2001; 53: 298-306.
28. Vulcano M, Albanesi C, Stoppacciaro A, et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 2001; 31: 812-822.
29. Hartl D. Immunological mechanisms behind the cysticf brosis-ABPA link. Med Mycol 2009; 47(Suppl. 1): S183-191.
30. Chotirmall SH, Branagan P, Gunaratnam C, McElvaney NG. Aspergillus/ allergic bronchopulmonary aspergillosis in an Irish cysticf brosis population: a diagnostically challenging entity. Respir Care 2008; 53: 1035-1041.
31. Becker JW, Burke W, McDonald G, et al. Prevalence of allergic bron-chopulmonary aspergillosis and atopy in adult patients with cysticf brosis. Chest 1996; 109: 1536-1540.
32. Knutsen AP, Noyes B, Warrier MR, Consolino J. Allergic bronchopul-monary aspergillosis in a patient with cysticf brosis: diagnostic criteria when the IgE level is less than 500 IU/mL. Ann Allergy Asthma Immunol 2005; 95: 488-493.
33. Schwartz RH, Hollick GE. Allergic bronchopulmonary aspergillosis with low serum immunoglobulin E. J Allergy Clin Immunol 1981; 68: 290-294.
34. Takhar P, Corrigan CJ, Smurthwaite L, et al. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J Allergy Clin Immunol 2007; 119: 213-218.
35. Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bron-chopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 1982; 96: 286-291.
36. Wark PA, Saltos N, Simpson J, et al. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J 2000; 16: 1095-1101.
37. Ricketti AJ, Greenberger PA, Patterson R. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1984; 74: 68-71.
38. Pacheco A, Martin JA, Cuevas M. Serologic response to itracon-azole in allergic bronchopulmonary aspergillosis. Chest 1993; 103: 980-981.
39. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 2006; 130: 442-448.
40. Bowyer P, Blightman O, Denning DW. Relative reactivity of Aspergillus allergens used in serological tests. Med Mycol 2006; 44: S23-28.
41. Crameri R, Lidholm J, Gronlund H, et al. Automated specif c IgE assay with recombinant allergens: evaluation of the recombinant Asper-gillus fumigatus allergen I in the Pharmacia Cap System. Clin Exp Allergy 1996; 26: 1411-1419.
42. Vailes L, Sridhara S, Cromwell O, et al. Quantitation of the major fungal allergens, Alt a 1 and Aspf 1, in commercial allergenic products. J Allergy Clin Immunol 2001; 107: 641-646.
43. Skov M, Koch C, Reimert CM, Poulsen LK. Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cysticf brosis. Allergy 2000; 55: 50-58.
44. Banerjee B, Kurup VP, Greenberger P, Johnson BD, Fink JN. Cloning and expression of Aspergillus fumigatus allergen f16 mediating both humoral and cell-mediated immunity in allergic bronchopulmonary aspergillosis (ABPA). Clin Exp Allergy 2001; 31: 761-770.
45. Crameri R, Limacher M, Weichel M, et al. Structural aspects and clinical relevance of Aspergillus fumigatus antigens/allergens. Med Mycol 2006; 44: S261-S267.
46. Gautam P, Sundaram CS, Madan T, et al. Identif cation of novel allergens of Aspergillus fumigatus using immunoproteomics approach. Clin Exp Allergy 2007; 37: 1239-1249.
47. Glaser AG, Kirsch AI, Zeller S, et al. Molecular and immunological characterization of Aspf 34, a novel major cell wall allergen of Asper-gillus fumigatus. Allergy 2009; 64: 1144-1151.
48. Chow LP, Liu SL, Yu CJ, et al. Identif cation and expression of an allergen Aspf 13 from Aspergillus fumigatus and epitope mapping using human IgE antibodies and rabbit polyclonal antibodies. Bio-chem J 2000; 346(Pt 2): 423-431.
49. Banerjee B, Kurup VP, Greenberger PA, et al. Purif cation of a major allergen, Aspf 2 binding to IgE in allergic bronchopulmonary asper-gillosis, from culturef ltrate of Aspergillus fumigatus. J Allergy Clin Immunol 1997; 99: 821-827.
50. De Oliveira E, Giavina-Bianchi P, Fonseca LA, Franca AT, Kalil J. Allergic bronchopulmonary aspergillosis diagnosis remains a challenge. Respir Med 2007; 101: 2352-2357.
51. Crameri R. Molecular cloning of Aspergillus fumigatus allergens and their role in allergic bronchopulmonary aspergillosis. Chem Immunol 2002; 81: 73-93.
52. Kurup VP. Aspergillus antigens: which are important? Med Mycol 2005; 43(Suppl. 1): S189-196.
53. Hutcheson PS, Knutsen AP, Rejent AJ, Slavin RG. A 12-year longitudinal study of Aspergillus sensitivity in patients with cysticf brosis. Chest 1996; 110: 363-366.
54. Kurup VP, Kumar A. Immunodiagnosis of aspergillosis. Clin Micro-biol Rev 1991; 4: 439-456.
55. Van Hoeyveld E, Dupont L, Bossuyt X. Quantif cation of IgG antibodies to Aspergillus fumigatus and pigeon antigens by ImmunoCAP technology: an alternative to the precipitation technique? Clin Chem 2006; 52: 1785-1793.
56. Schonheyder H, Jensen T, Laessoe IH, Hoiby N, Koch C. Serum antibodies to Aspergillus fumigatus catalase in patients with cysticf bro-sis. Eur J Clin Microbiol Infect Dis 1988; 7: 40-44.
57. Cimon B, Carrere J, Chazalette JP, et al. Fungal colonization and immune response to fungi in cysticf brosis. J Mycol Med 1995; 5: 211-216.
58. Brummund W, Resnick A, Fink JN, Kurup VP. Aspergillus fumigatus-specif c antibodies in allergic bronchopulmonary aspergillosis and aspergilloma: evidence for a polyclonal antibody response. J Clin Microbiol 1987; 25: 5-9.
59. Trull AK, Parker J, Warren RE. IgG enzyme linked immunosorbent assay for diagnosis of invasive aspergillosis: retrospective study over 15 years of transplant recipients. J Clin Pathol 1985; 38: 1045-1051.
60. Piechura JE, Kurup VP, Daft LJ. Isolation and immunochemical characterization of fractions from membranes of Aspergillus fumigatus with protease activity. Can J Microbiol 1990; 36: 33-41.
61. Longbottom JL, Harvey C, Taylor ML, et al. Characterization of immunologically important antigens and allergens of Aspergillus fumigatus. Int Arch Allergy Appl Immunol 1989; 88: 185-186.
62. Kurup VP, Greenberger PA, Fink JN. Antibody response to low-molecular-weight antigens of Aspergillus fumigatus in allergic bron-chopulmonary aspergillosis. J Clin Microbiol 1989; 27: 1312-1316.
63. Edwards JH, Alfaham M, Fifeld R, et al. Sequential serological responses to Aspergillus fumigatus in patients with cysticf brosis. Use of antigen 'stretching' to delineate IgG and IgE activity. Clin Exp Immunol 1990; 81: 101-108.
64. Chan CM, Woo PC, Leung AS, et al. Detection of antibodies specif c to an antigenic cell wall galactomannoprotein for serodiagnosis of Aspergillus fumigatus aspergillosis. J Clin Microbiol 2002; 40: 2041-2045.
65. Sarfati J, Monod M, Recco P, et al. Recombinant antigens as diagnostic markers for aspergillosis. Diagn Microbiol Infect Dis 2006; 55: 279-291.
66. Weig M, Frosch M, Tintelnot K, et al. Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol 2001; 39: 1721-1730. (Pubitemid 32417011)
67. Richardson MD, Stubbins JM, Warnock DW. Rapid enzyme-linked immunosorbent assay (ELISA) for Aspergillus fumigatus antibodies. J Clin Pathol 1982; 35: 1134-1137.
68. Faux JA, Shale DJ, Lane DJ. Precipitins and specifcIg G antibody to Aspergillus fumigatus in a chest unit population. Thorax 1992; 47: 48-52.
69. Kauffman HF, Beaumont F, Meurs H, Van Der Heide S, De Vries K. Comparison of antibody measurements against Aspergillus fumigatus by means of double-diffusion and enzyme-linked immunosorbent assay (ELISA). J Allergy Clin Immunol 1983; 72: 255-261.
70. Smith JM, Derks AA. Serological tests in the diagnosis of pulmonary aspergillosis. Pathology 1984; 16: 184-188.
71. Sandhu RS, Bardana EJ, Khan ZU, Dordevich DM. Allergic bron-chopulmonary aspergillosis (ABPA): studies on the general and specif c humoral response. Mycopathologia 1978; 63: 21-27.
72. Kauffman HF, Van Der Heide S, Beaumont F, Blok H, de Vries K. Class-specif c antibody determination against Aspergillus fumigatus by means of the enzyme-linked immunosorbent assay. III. Comparative study: IgG, IgA, IgM ELISA titers, precipitating antibodies and IgE binding after fractionation of the antigen. Int Arch Allergy Appl Immunol 1986; 80: 300-306.
73. Kauffman HF, Koeter GH, Van der Heide S, et al. Cellular and humoral observations in a patient with allergic bronchopulmonary aspergillosis during a nonasthmatic exacerbation. J Allergy Clin Immunol 1989; 83: 829-838.
74. Kurup VP, Resnick A, Kalbf eish J, Fink JN. Antibody isotype responses in Aspergillus -induced diseases. J Lab Clin Med 1990; 115: 298-303.
75. Knutsen AP, Mueller KR, Hutcheson PS, Slavin RG. Serum anti-Aspergillus fumigatus antibodies by immunoblot and ELISA in cysticf brosis with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1994; 93: 926-931.
76. Skov M, Pandey JP, Pressler T, Hoiby N, Koch C. Immunoglobulin allotypes and IgG subclass antibody response to Aspergillus fumigatus in cysticf brosis patients. J Cyst Fibros 2004; 3: 173-178.
77. Trompelt J, Becker WM, Schlaak M. Analysis of IgG subclass and IgE response in allergic disease caused by Aspergillus fumigatus by immu-noblotting techniques. Int Arch Allergy Immunol 1994; 104: 390-398.
78. Tomee JF, Dubois AE, Koeter GH, et al. Specif c IgG4 responses during chronic and transient antigen exposure in aspergillosis. Am J Respir Crit Care Med 1996; 153: 1952-1957.
79. Greenberger PA, Smith LJ, Hsu CC, Roberts M, Liotta JL. Analysis of bronchoalveolar lavage in allergic bronchopulmonary aspergillo-sis: divergent responses of antigen-specif c antibodies and total IgE. J Allergy Clin Immunol 1988; 82: 164-170.
80. Gutt L, Greenberger PA, Liotta JL. Serum IgA antibodies to Aspergil-lus fumigatus in various stages of allergic bronchopulmonary aspergil-losis. J Allergy Clin Immunol 1986; 78: 98-101.
81. Patterson R, Roberts M, Ghory AC, Greenberger PA. IgA antibody against Aspergillus fumigatus antigen in patients with allergic bronchopulmonary aspergillosis. Clin Exp Immunol 1980; 42: 395-398.
82. Gibson PG, Wark PA, Simpson JL, et al. Induced sputum IL-8 gene expression, neutrophil inf ux and MMP-9 in allergic bronchopulmo-nary aspergillosis. Eur Respir J 2003; 21: 582-588.
83. McAllister F, Henry A, Kreindler JL, et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inf ammation in cysticf brosis. J Immunol 2005; 175: 404-412.
84. Brouard J, Knauer N, Boelle P Y, et al. Inf uence of interleukin-10 on Aspergillus fumigatus infection in patients with cysticf brosis. J Infect Dis 2005; 191: 1988-1991.
85. Sambatakou H, Pravica V, Hutchinson I V, Denning DW. Cytokine prof ling of pulmonary aspergillosis. Int J Immunogenet 2006; 33: 297-302.
86. Agarwal R, Gupta D, Aggarwal AN, et al. Clinical signif cance of decline in serum IgE levels in allergic bronchopulmonary aspergil-losis. Respir Med 2010; 104: 204-210.
87. Fall BI, Niessner R. Detection of known allergen-specif c IgE antibodies by immunological methods. Methods Mol Biol 2009; 509: 107-122.
88. Apter AJ, Greenberger PA, Liotta JL, Roberts M. Fluctuations of serum IgA and its subclasses in allergic bronchopulmonary aspergil-losis. J Allergy Clin Immunol 1989; 84: 367-372.